Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 93

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Staphylococcus aureus biofilms: Structures, antibiotic resistance, inhibition, and vaccines

Parastan, Raziey, Kargar, Mohammad, Solhjoo, Kavous, Kafilzadeh, Farshid · 2020 · Gene Reports

Abstract

Abstract Biofilm formation in Staphylococcus aureus causes an increase in antibiotics resistance in chronic diseases, including osteomyelitis, endocarditis, and wound infection. The S. aureus biofilm structure is composed of polysaccharide, protein, and external DNA. Bacterial cells in the biofilm compose of resistant persister cells and exhibit multidrug resistance. The emergence of multidrug resistant S. aureus strains is a health problem now. In the S. aureus biofilm state, susceptibility to antibiotics even vancomycin is reduced and eradication of bacteria is challenging. In the present review, we studied the structure of biofilm, antibiotic resistant in biofilm state, and biofilm prevention strategies in S. aureus. Infections due to S. aureus are expensive and susceptibility to antibiotics is reduced in biofilm state and several methods, including anti-biofilm agents and vaccine should be applied to treat diseases related to biofilm. For prevention and inhibition of biofilm, application of antiadhesion agents and vaccines based on biofilm genes is recommended. Multivalent vaccines based on biofilm genes, including clumping factor A, poly-β (1-6)-N-acetylglucosamine, collagen adhesin, and fibronectin binding protein in S. aureus can be beneficial for preventing initial attachment and biofilm formation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.genrep.2020.100739

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 8 references

Research works printed but not linked: 72

  1. Anderson, 2016, Staphylococcus aureus clumping factor A remains a viable vaccine target for prevention of S. aureus infection, mBio, 7, 10.1128/mBio.00225-16 · DOI
  2. Ansari, 2017, Antimicrobial resistant determination and prokaryotic expression of smpA gene of Acinetobacter baumannii isolated from admitted patients, Jundishapur J. Microbiol., 10, 10.5812/jjm.59370 · doi:10.5812/jjm.59370
  3. Ansari, 2019, Recent advances in Staphylococcus aureus infection: focus on vaccine development, Infection Drug Resis., 12, 1243, 10.2147/IDR.S175014 · DOI
  4. Archer, 2011, Staphylococcus aureus biofilms properties, regulation and roles in human disease, Virulence, 2, 445, 10.4161/viru.2.5.17724 · DOI · Paper page
  5. Arciola, 2015, Polysaccharide intercellular adhesion in biofilm: structural and regulatory aspects, Front. Cell. Infect. Microbiol., 5, 1, 10.3389/fcimb.2015.00007 · DOI · Paper page
  6. Asadi, 2014, The association of virulence determinants of uropathogenic Escherichia coli with antibiotic resistance, Jundishapur J. Microbiol., 7
  7. Bashore, 2006, Update on infective endocarditis, Curr. Probl. Cardiol., 31, 274, 10.1016/j.cpcardiol.2005.12.001 · DOI · Paper page
  8. Bhattacharya, 2015, Prevention and treatment of Staphylococcus aureus biofilms, Expert Rev. Anti-Infect. Ther., 13, 1499, 10.1586/14787210.2015.1100533 · DOI · Paper page
  9. Boles, 2011, Staphylococcal biofilms disassembly, Trends Microbiol., 19, 449, 10.1016/j.tim.2011.06.004 · DOI · Paper page
  10. Cerca, 2008, Regulation of the intercellular adhesion locus regulator (ica R) by SarA, SigmaB,and IcaR in Staphylococcus aureus, J. Bacteriol., 190, 6530, 10.1128/JB.00482-08 · DOI
  11. Chancey, 2012, Acquired inducible antimicrobial resistance in Gram-positive bacteria, Future Microbiol., 7, 959, 10.2217/fmb.12.63 · DOI
  12. Costerton, 1978, How bacteria stick, Sci. Am., 238, 86, 10.1038/scientificamerican0178-86 · DOI · Paper page
  13. Cue, 2009, Rbf promotes biofilm formation by Staphylococcus aureus via repression of icaR, a negative regulator of ica ADBC, J. Bacteriol., 191, 6363, 10.1128/JB.00913-09 · DOI
  14. Denis, 2017, Route of transmission of Staphylococcus aureus, Lancet Infect. Dis., 17, 117, 10.1016/S1473-3099(16)30512-6 · DOI
  15. Eriksson, 2017, Antibacterial and antibiofilm effects of sodium hypochlorite against Staphylococcus aureus isolates derived from patients with atopic dermatitis, BJD, 177, 513, 10.1111/bjd.15410 · DOI
  16. Fischer, 1996, Novel animal model for studying the molecular mechanisms of bacterial adhesion to bone-implanted metallic devices: role of fibronectin in Staphylococcus aureus adhesion, J. Orthop. Res., 14, 914, 10.1002/jor.1100140611 · DOI
  17. Fisher, 2017, Persistent bacterial infections and persister cells, Nat. Rev. Microbiol., 15, 453, 10.1038/nrmicro.2017.42 · DOI · Paper page
  18. Foster, 2014, Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus, Nat. Rev. Microbiol., 12, 49, 10.1038/nrmicro3161 · DOI · Paper page
  19. Ghorbani-Dalinia, 2015, Molecular epidemiology of ESBLs genes and multi-drug resistance in diarrheagenic Escherichia Coli strains isolated from adults in Iran, Iranian J. Pharmaceut. Res., 14, 1257
  20. Giersing, 2016, Status of vaccine research and development of vaccines for Staphylococcus aureus, Vaccine, 34, 2962, 10.1016/j.vaccine.2016.03.110 · DOI
  21. Harro, 2010, Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration, FEMS Immunol. Med. Microbiol., 59, 306, 10.1111/j.1574-695X.2010.00708.x · DOI
  22. Hassett, 1999, Quorum sensing in Pseudomonas aeruginosa controls expression of catalase and superoxide dismutase genes and mediates biofilm susceptibility to hydrogen peroxide, Mol. Microbiol., 34, 1082, 10.1046/j.1365-2958.1999.01672.x · DOI · Paper page
  23. Hogan, 2008, Novel treatment of Staphylococcus aureus device-related infections using fibrinolytic agents, Antimicrob. Agents Chemother., 62
  24. HΦiby, 2010, Antibiotic resistance of bacterial biofilms, Int. J. Antimicrob. Agents, 35, 322, 10.1016/j.ijantimicag.2009.12.011 · DOI · Paper page
  25. Ivanova, 2018, Layer-by-layer decorated nanoparticles with tunable antibacterial and antibiofilm properties against both Gram-positive and Gram-negative bacteria, ACS Appl. Mater. Interfaces, 10, 3314, 10.1021/acsami.7b16508 · DOI
  26. Jefferson, 2004, The teicoplanin-associated locus regulator (Tca R) and the intercellular adhesin locus regulator (IcaR) are transcriptional inhibitors of the ica locus in Staphylococcus aureus, J. Bacteriol., 186, 2449, 10.1128/JB.186.8.2449-2456.2004 · DOI · Paper page
  27. Josefsson, 2001, Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant, J. Infect. Dis., 184, 1572, 10.1086/324430 · DOI · Paper page
  28. Kargar, 2012, Real-time PCR for Helicobacter pylori quantification and detection of clarithromycin resistance in gastric tissue from patients with gastrointestinal disorders, Res. Microbiol., 163, 109, 10.1016/j.resmic.2011.11.005 · DOI
  29. Kargar, 2014, Resistance to different generations of quinolones in Streptococcus pneumoniae strains isolated from hospitals in Shiraz, Comp. Clin. Pathol., 24
  30. Kargar, 2014, High prevalence of class 1 to 3 integrons among multidrug-resistant diarrheagenic Escherichia coli in southwest of Iran, Osong Public Health Res. Perspect., 5, 193, 10.1016/j.phrp.2014.06.003 · DOI
  31. Khan, 2015, Investigational therapies targeting quorum-sensing for the treatment of Staphylococcus aureus infections, Expert Opin. Investig. Drugs, 24, 689, 10.1517/13543784.2015.1019062 · DOI
  32. Lasa, 2006, Bap: a family of surface proteins involved in biofilm formation, Res. Microbiol., 157, 99, 10.1016/j.resmic.2005.11.003 · DOI · Paper page
  33. Levy, 2015, Safety and immunogenicity of an investigational 4-component Staphylococcus aureus vaccine with or without AS03 adjuvant: results of a randomized phase I trial, Hum. Vaccin. Immunother., 11, 620, 10.1080/21645515.2015.1011021 · DOI
  34. Li, 2018, Biological characteristics and conjugated antigens of Clf A-FnBPA and CP5 in Staphylococcus aureus, Can. J. Vet. Res., 82, 48
  35. Liu, 2018, The influence of cell and substratum surface on hydrophobicities on microbial attachment, J. Biotechnol., 110, 251, 10.1016/j.jbiotec.2004.02.012 · DOI · Paper page
  36. Lu, 2007, Dispersing biofilms with engineered enzymatic bacteriophage, PNAS, 104, 11197, 10.1073/pnas.0704624104 · DOI · Paper page
  37. Maira-Litrán, 2002, Immunochemical properties of the Staphylococcal N-acetylglucosamine surface polysaccharide, Infect. Immun., 70, 4433, 10.1128/IAI.70.8.4433-4440.2002 · DOI · Paper page
  38. Maira-Litrán, 2012, Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A, PLOS, 7
  39. Mashruwala, 2017, Impaired respiration elicits Srr AB-dependent programmed cell lysis and biofilm formation in Staphylococcus aureus, eLife, 6, 10.7554/eLife.23845 · DOI · Paper page
  40. McDonald, 1970, Immunochemical analysis of a uronic acid polymer of Staphylococcus Epidermidis, strain 53, Karakawa J. Immunol., 105, 389, 10.4049/jimmunol.105.2.389 · doi:10.4049/jimmunol.105.2.389
  41. McGuiness, 2017, Vancomycin resistance in Staphylococcus aureus, YJBM, 90, 269
  42. McKenney, 1999, Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen, Science, 284, 1523, 10.1126/science.284.5419.1523 · DOI · Paper page
  43. Morris, 2018, Evaluation of bacteriophage anti-biofilm activity for potential control of orthopedic implant-related infections caused by Staphylococcus aureus, Surg. Infect., 20
  44. Mulcahy, 2016, Host–bacterial crosstalk determines Staphylococcus aureus nasal colonization, Trends Microbiol., 24, 872, 10.1016/j.tim.2016.06.012 · DOI
  45. Murugan, 2010, Biofilm forming multidrug resistant Staphylococcus spp. among patients with conjunctivitis, Pol. J. Microbiol., 59, 233, 10.33073/pjm-2010-036 · DOI
  46. Nissen, 2015, A randomized phase I study of the safety and immunogenicity of three ascending dose levels of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults, Vaccine, 33, 1846, 10.1016/j.vaccine.2015.02.024 · DOI
  47. O’Rourke, 2014, Development of a mimotope vaccine targeting the Staphylococcus aureus quorum sensing pathway, PLoS One, 9, 10.1371/journal.pone.0111198 · DOI
  48. Pamp, 2006, Spx is a global effector impacting stress tolerance and biofilm formation in Staphylococcus aureus, J. Bacteriol., 188, 4861, 10.1128/JB.00194-06 · DOI · Paper page
  49. Panda, 2020, Indian medicinal plant extracts to control multidrug-resistant S. aureus, including in biofilms, S. Afr. J. Bot., 128, 283, 10.1016/j.sajb.2019.11.019 · doi:10.1016/j.sajb.2019.11.019
  50. Pappelbaum, 2013, Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress, Circulation, 128, 50, 10.1161/CIRCULATIONAHA.113.002008 · DOI
  51. Parastan, 2020, A synergistic association between adhesion-related genes and multidrug resistance patterns of Staphylococcus aureus isolates from different patients and healthy individuals, JGAR
  52. Peters, 2010, Microbial interactions and differential protein expression in Staphylococcus aureus-Candida albicans dual-species biofilms, FEMS Immunol. Med. Microbiol., 59, 493, 10.1111/j.1574-695X.2010.00710.x · DOI · Paper page
  53. Piroth, 2008, The fibrinogen- and fibronectin-binding domains of Staphylococcus aureus fibronectin-binding protein A synergistically promote endothelial invasion and experimental endocarditis, Infect. Immun., 76, 3824, 10.1128/IAI.00405-08 · DOI
  54. Poulsen, 1993, Use of rRNA fluorescence in situ hybridization for measuring the activity of single cells in young and established biofilms, Appl. Environ. Microbiol., 59, 1354, 10.1128/aem.59.5.1354-1360.1993 · DOI · Paper page
  55. Rao, 2011, Treating osteomyelitis: antibiotics and surgery, Plast. Reconstr. Surg., 127, 177S, 10.1097/PRS.0b013e3182001f0f · DOI · Paper page
  56. Rhem, 2000, The collagen-binding Adhesin is a virulence factor in Staphylococcus aureus keratitis, Infect. Immun., 68, 3776, 10.1128/IAI.68.6.3776-3779.2000 · DOI
  57. Sass, 2007, Lytic activity of recombinant bacteriophage Φ11 and Φ12 endolysins on whole wells and biofilms of Staphylococcus aureus, Appl. Environ. Microbiol., 73, 347, 10.1128/AEM.01616-06 · DOI · Paper page
  58. Schuch, 2017, Bacteriophage Lysin CF-301, a potent antistaphylococcal biofilm agent, Antimicrob. Agents Chemother., 61, 10.1128/AAC.02666-16 · DOI · Paper page
  59. Scully, 2018, O-acetylation is essential for functional antibody generation against Staphylococcus aureus capsular polysaccharide, Hum. Vaccin. Immunother., 14, 81, 10.1080/21645515.2017.1386360 · doi:10.1080/21645515.2017.1386360
  60. Serra, 2015, Chronic wound infections: the role of Pseudomonas aeruginosa and Staphylococcus aureus, Expert Rev. Anti-Infect. Ther., 13, 605, 10.1586/14787210.2015.1023291 · DOI · Paper page
  61. Sharma, 2018, Phage-derived lysins as potential agents for eradicating biofilms and persisters, Drug Discov. Today, 23, 848, 10.1016/j.drudis.2018.01.026 · DOI
  62. Shenkman, 2002, Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions, J. Med. Microbiol., 51, 747, 10.1099/0022-1317-51-9-747 · doi:10.1099/0022-1317-51-9-747
  63. Shirtliff, 2009, Cross-kingdom interactions: Candida albicans and bacteria, FEMS Microbiol. Lett., 299, 1, 10.1111/j.1574-6968.2009.01668.x · DOI · Paper page
  64. Shokravi, 2015, Detecting the frequency of aminoglycoside modifying enzyme encoding genes among clinical isolates of methicillin-resistant Staphylococcus aureus, BI, 5, 87, 10.15171/bi.2015.15 · DOI · Paper page
  65. Siboo, 2005, Role of SraP, a serine-rich surface protein of Staphylococcus aureus in binding to human platelets, Infect. Immun., 73, 2273, 10.1128/IAI.73.4.2273-2280.2005 · DOI · Paper page
  66. Singh, 2018, In silico identification of albendazole as a quorum sensing inhibitor and its in vitro verification using CviR and Las B receptors based assay systems, BI, 8, 201, 10.15171/bi.2018.23 · DOI
  67. Stewart, 2003, Diffusion in biofilms, J. Bacteriol., 185, 1485, 10.1128/JB.185.5.1485-1491.2003 · DOI · Paper page
  68. Tuomanen, 1986, The rate of killing of Escherichia coli by beta lactam antibiotics is strictly proportional to the rate of bacterial growth, J. Gen. Microbiol., 132, 1297
  69. Vaishampayan, 2018, A novel antimicrobial coating represses biofilm and virulence-related genes in methicillin-resistant Staphylococcus aureus, Front. Microbiol., 9, 221, 10.3389/fmicb.2018.00221 · DOI
  70. Xu, 2017, Safety of Staphylococcus aureus four-antigen and three-antigen vaccines in healthy adults: a meta-analysis of randomized controlled trials(?), Hum. Vaccin. Immunother., 14, 314, 10.1080/21645515.2017.1395540 · doi:10.1080/21645515.2017.1395540
  71. Yarwood, 2004, Quorum sensing in Staphylococcus aureus biofilms, J. Bacteriol., 186, 1838, 10.1128/JB.186.6.1838-1850.2004 · DOI · Paper page
  72. Zhou, 2006, An immunogenicity study of a newly fusion protein Cna-FnBP vaccinated against Staphylococcus aureus infections in a mice model, Vaccine, 24, 4830, 10.1016/j.vaccine.2006.03.020 · DOI

Cited by

Metadata

Authors
Parastan, R., Kargar, M., Solhjoo, K., & Kafilzadeh, F.
Venue
Gene Reports
Publisher
Elsevier BV
Published
2020-09
Volume
20
Pages
100739
ISSN
2452-0144
Cited by
93
References
8
Language
en
Funders
Islamic Azad University

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.